FOXP3 and neoplasm: By breeding APCmin/+ mice with depletion of regulatory T cell (DEREG) mice, which harbour a high affinity diphtheria toxin (DT) receptor under the control of the FOXP3 promoter [28], we were able to deplete Treg by DT injections in tumor-bearing mice.